Vijay Karwal | Chief Financial Officer, AffaMed Therapeutics & Operating Partner, CBC Group
Vijay Karwal serves as AffaMed’s CFO and brings over 25 years of financial management and advisory experience in the healthcare industry. He is also an Operating Partner of CBC Group. Vijay joined AffaMed from Nomura International in Hong Kong, where he served as Managing Director and Head of Healthcare Investment Banking for the Asia (ex-Japan) region. Prior to Nomura, he was Chief Development Officer, Asia Pacific, as well as General Manager of China operations for DaVita Inc., the international provider of kidney care services. Vijay previously held several senior investment banking roles globally, including as Asia Pacific Head of Consumer, Retail & Healthcare coverage at RBS, and as Head of Healthcare Banking in North America at ABN AMRO. A native of the Netherlands, Vijay was educated at the University of Southampton, UK, and the University of Groningen, the Netherlands, holds a M.Sc. in Economics, and is also a CFA charterholder.
About AffaMed Therapeutics
AffaMed Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs in ophthalmic, neurological and psychological disorders for patients in Greater China and around the world. The leadership team of AffaMed Therapeutics has gained deep industry expertise and an extensive track record in high-quality clinical development, regulatory affairs, CMC, business development and commercial operations at leading multi-national pharmaceutical companies in China and globally. AffaMed Therapeutics was founded and funded by the CBC Group in 2019.
About CBC Group
CBC Group (formerly C-Bridge Capital) is one of the largest and most active healthcare-dedicated investment firms in Asia with current AuM in excess of USD 4.5 billion, and is focused on platform-building and buyout opportunities across three core areas within the healthcare sector: pharmaceutical & biotech, medtech and healthcare services. CBC's operationally intensive approach empowers healthcare sector champions to make transformative changes to enable sustainable long-term growth, fulfill unmet medical needs and continuously improve the standard of living and quality of care in China and the rest of Asia. Founded in 2014, CBC has a strong team of investment, healthcare and portfolio management professionals based across Singapore, Shanghai, Beijing, Hong Kong, and New York.
Sponsors & Partners
| Powered by: Hyphen Projects | Connect with us | Access Biotech China Newsletter | ||
| Contact Us Privacy Policy Terms & Conditions Chamber of Commerce: 32110979 VAT no: NL8184.34.491.B01 |
| Subscribe
|
© Copyright 2021 by Hyphen Projects